Lotus Pharmaceutical Co., Ltd. (TPE:1795)

Lotus Pharmaceutical Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Lotus Pharmaceutical stock has a consensus rating of "Buy" and an average price target of $367.00. The average 1-year stock price forecast is 84.89% higher than the current stock price, while the lowest is $200.00 (+0.76%) and the highest is $500.00 (+151.89%).

Price Target: $367.00 (+84.89%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$200.00	$367.00	$384.00	$500.00
Change	+0.76%	+84.89%	+93.45%	+151.89%

Analyst Ratings

The average analyst rating for Lotus Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Mar '26	Apr '26	May '26
Strong Buy	3	3	3	1	1	1
Buy	2	2	2	3	2	2
Hold	0	0	0	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	4	4

Financial Forecast

Revenue This Year

35.80B

Increased by 74.57%

from 20.51B

Revenue Next Year

40.95B

Increased by 14.36%

from 35.80B

EPS This Year

13.43

Decreased by -25.98%

from 18.14

EPS Next Year

23.37

Increased by 74.02%

from 13.43

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	12.65B	14.63B	16.96B	18.58B	20.51B	35.80B
Revenue Growth	17.90%	15.68%	15.89%	9.59%	10.36%	74.57%
Gross Profit	5.64B	7.81B	9.38B	10.92B	11.91B	18.96B
Gross Margin	44.59%	53.35%	55.34%	58.78%	58.05%	52.95%
Operating Income	2.53B	4.25B	5.08B	6.18B	6.21B	8.88B
Net Income	1.40B	3.02B	4.11B	5.07B	4.72B	3.54B
EPS	-	-	-	-	18.14	13.43
EPS Growth	-	-	-	-	-6.25%	-25.98%
Forward PE	15.41	18.39	15.36	12.05	11.05	14.78
Dividend / Share	1.93	3.46	4.66	5.73	2.56	2.69
Dividend Growth	-	79.27%	34.68%	22.96%	-55.32%	5.08%
Free Cash Flow	-1.80B	1.92B	-4.30B	3.20B	3.37B	-1.22B
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is TWD.

Revenue Forecast

Revenue	2026	2027	2028
High	36.8B
Avg	35.8B
Low	34.7B

Revenue Growth

Revenue Growth	2026	2027	2028
High	79.6%
Avg	74.6%
Low	69.3%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	13.43
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-26.0%
Low	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.